Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Algorae Pharmaceuticals Logo
Algorae Pharmaceuticals Growth Score
90
CB Rank
168926
Heat Score
61
Algorae Pharmaceuticals is an Australasian biotechnology company
Founded
obfuscation
PublicPost-IPO Equity Manukau City, Auckland, New Zealand1-10 algoraepharma.com
Biotechnology
Diabetes
Health Care
Health Diagnostics
Overview

Algorae Pharmaceuticals
Total Funding
obfuscation
Growth Score
90
Heat Score
61

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score90
-5 pts
in past quarter
Heat Score 61
0 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Algorae Pharmaceuticals

CB Rank
168926
Algorae Pharmaceuticals is an Australasian biotechnology company
Founded
obfuscation
PublicPost-IPO Equity Manukau City, Auckland, New Zealand1-10 algoraepharma.com
Biotechnology
Diabetes
Health Care
Health Diagnostics

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Post-IPO Debt
OBF
in
obfuscation
Grant
OBF
in
obfuscation

Key People

Details

Legal Name LIVING CELL TECHNOLOGIES LTD
Also Known As Living Cell Technologies
Operating Status Active
Stock Symbol  ASX:1AI
Company Type For Profit
Founders  Robert Elliott
About the Company
Algorae Pharmaceuticals is an Australasian biotechnology company working on AI-enhanced drug research and discovery initiatives to improve the health of individuals
Phone Number 64 9 276 2690
Contact Email info@lctglobal.com
Predictions & Insights

Products & Services

AlgoraeOS
An AI-driven drug discovery platform that integrates diverse biomedical data to identify and develop novel drug candidates.
AI-168
A combination drug candidate composed of a cannabinoid and an off-patent pharmaceutical ingredient targeting cardiovascular disease treatment.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Algorae Pharmaceuticals Logo
Post-IPO Equity - Algorae Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Algorae Pharmaceuticals Logo
Post-IPO Equity - Algorae Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Algorae Pharmaceuticals Logo
Post-IPO Equity - Algorae Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Algorae Pharmaceuticals Logo
Post-IPO Equity - Algorae Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Algorae Pharmaceuticals Logo
Post-IPO Equity - Algorae Pharmaceuticals
—
obfuscation
— Post-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Algorae Pharmaceuticals Logo
Post-IPO Equity - Algorae Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Algorae Pharmaceuticals Logo
Post-IPO Equity - Algorae Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Algorae Pharmaceuticals Logo
Post-IPO Equity - Algorae Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Algorae Pharmaceuticals Logo
Post-IPO Equity - Algorae Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Algorae Pharmaceuticals Logo
Post-IPO Equity - Algorae Pharmaceuticals
—
obfuscation
— Post-IPO Equity

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 2 Contacts 2

Employee Profiles

News

News and Press

News•Mar 30, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Feb 11, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Actively Used Products

8Algorae Pharmaceuticals uses 8 technology products and services including HTML5, jQuery, and  Adobe Fonts, according to G2 Stack.

Active Website Tech Count

5Algorae Pharmaceuticals is actively using 5 technologies for its website, according to BuiltWith. These include Euro, CommonCrawl Top 10m, and  Pound Sterling.
Sub-Organizations
Frequently Asked Questions

Where is Algorae Pharmaceuticals's headquarters? Algorae Pharmaceuticals is located in Manukau City, Auckland, New Zealand.Who invested in Algorae Pharmaceuticals? Algorae Pharmaceuticals has 2 investors including ScotPac Business Finance and  Callaghan Innovation.When was the last funding round for Algorae Pharmaceuticals? Algorae Pharmaceuticals closed its last funding round on
obfuscation
from a Post-IPO Equity round.How much funding has Algorae Pharmaceuticals raised to date? Algorae Pharmaceuticals has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(5eb04bf 1)
|